12.03.2024 | Tracker
Top 50 Pharma Tracker: Pfizer’s Super Bowl advert is a touchdown for eHCPs
By Aman Jandu Discover what healthcare professionals (eHCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are eHCPs responding to drug launch news? How are eHCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of eHCPs across the globe discussing these topics and more.
The Top 50 Pharmaceutical Companies mentioned by eHCPs on X
| February Rank | January Rank | Company Name | Total Mentions | Account Mentions | Account Retweets |
|---|---|---|---|---|---|
| 1 | 1 | Pfizer | 2,320 | 175 | 2 |
| 2 | 2 | Moderna | 1,645 | 59 | 0 |
| 3 | 3 | Johnson & Johnson | 722 | 214 | 7 |
| 4 | 4 | AstraZeneca | 685 | 401 | 13 |
| 5 | 7 | Bayer | 464 | 91 | 7 |
| 6 | 5 | GSK | 361 | 118 | 13 |
| 7 | 14 | AbbVie | 250 | 215 | 4 |
| 8 | 6 | Novavax | 208 | 8 | 0 |
| 9 | 19 | Takeda | 189 | 172 | 0 |
| 10 | 10 | Roche | 166 | 67 | 12 |
| 11 | 17 | Abbott | 163 | 153 | 8 |
| 12 | 11 | Novo Nordisk | 159 | 64 | 3 |
| 13 | 13 | Sanofi | 147 | 63 | 8 |
| 14 | 18 | Gilead Sciences | 132 | 56 | 1 |
| 14 | 9 | Lilly | 128 | 73 | 0 |
| 16 | 22 | BMS | 115 | 60 | 1 |
| 17 | 8 | BioNTech | 103 | 3 | 0 |
| 18 | 25 | Amgen | 101 | 71 | 4 |
| 19 | 14 | Novartis | 96 | 40 | 1 |
| 20 | 12 | Merck & Co | 94 | 36 | 5 |
| 21 | 23 | Boehringer Ingelheim | 87 | 74 | 1 |
| 22 | 27 | Biogen | 82 | 24 | 1 |
| 23 | 31 | Daiichi Sankyo | 74 | 17 | 3 |
| 24 | 20 | Organon | 48 | 2 | 0 |
| 25 | 25 | Regeneron | 33 | 17 | 2 |
| 25 | 28 | Otsuka | 33 | 17 | 0 |
| 27 | 35 | UCB | 31 | 31 | 15 |
| 28 | 31 | Astellas | 29 | 20 | 1 |
| 29 | 21 | Servier | 28 | 18 | 15 |
| 29 | 28 | Fresenius | 28 | 18 | 1 |
| 31 | 24 | Vertex | 19 | 17 | 6 |
| 32 | 16 | Grifols | 15 | 0 | 0 |
| 32 | 30 | Eisai | 15 | 2 | 0 |
| 34 | 37 | Bausch | 14 | 2 | 1 |
| 35 | 39 | Teva | 11 | 4 | 2 |
| 36 | 42 | Incyte | 9 | 8 | 1 |
| 37 | 33 | Viatris | 8 | 0 | 0 |
| 37 | 36 | Ipsen | 8 | 3 | 0 |
| 37 | 40 | CSL | 8 | 6 | 1 |
| 40 | 50 | Perrigo | 7 | 6 | 0 |
| 41 | 43 | Jazz Pharmaceuticals | 6 | 3 | 0 |
| 42 | 34 | Merck KGaA | 5 | 0 | 0 |
| 43 | 37 | Menarini | 2 | 0 | 0 |
| 43 | 40 | Sun | 2 | 0 | 0 |
| 43 | 44 | Chugai | 2 | 0 | 0 |
| 46 | 45 | Horizon | 1 | 1 | 0 |
| 50 | 50 | CSPC | 0 | 0 | 0 |
| 50 | 50 | Shanghai | 0 | 0 | 0 |
| 50 | 50 | Sino | 0 | 0 | 0 |
| 50 | 50 | Jiangsu Hengrui | 0 | 0 | 0 |
The latest insights from eHCPs mentioning the Top 50 Pharmaceutical Companies
The five pharmaceutical companies that were mentioned the most by eHCPs on X in February 2024 were Pfizer, Moderna, Johnson & Johnson, AstraZeneca and Bayer.
CREATION.co identified 8,333 eHCP mentions of pharmaceutical companies in February 2024, decreasing by 2% over the previous month.
On 12 February, eHCPs discussed the new Pfizer advert shown at the Super Bowl – particularly celebrating its focus on the “Let’s Outdo Cancer” tagline.
Having a good time
Watching a science tribute
Yas, Queen! Cure cancer! #SuperBowlHaiku#rosalindfranklin @pfizer #Super Bowl #superbowlads— Amy Shriver, MD (she/her)🏳️🌈🏳️⚧️ (@shriver_amy) February 12, 2024
The advert showcased many influential scientific figures, from Galileo to Einstein. The inclusion of Katalin Kariko – the scientist who discovered the COVID-19 vaccine – was cause for celebration amongst the eHCP community. Oncologist Vivek Subbiah took the opportunity to celebrate these figures, and also shared the tagline of “Let’s Outdo Cancer”.
⭐️Surprise! Pfizer Super Bowl ad #SuperBowlLVIII featuring Galileo, Copernicus, Newton, Einstein, Marie Maynard Daly, Rosalind Franklin & the one & only @kkariko Let’s outdo cancer
— Vivek Subbiah, MD (@VivekSubbiah) February 12, 2024
On 26 February, epidemiologist Daniel Park shared an article looking at the 1 year durability data of the Novavax COVID-19 vaccine – calling it “pretty remarkable”. His post was shared by 17 eHCPs.
Just released: Pretty remarkable 1-year durability data for Novavax 2-dose primary series. Though there is some expected waning, there was >65% efficacy at 1y (mRNA options typically wane to this level by ~4-5 months). Also fewer waning differences by age.https://t.co/OtJwxbn9zM pic.twitter.com/20Jwmchi6w
— Daniel Park (@Daniel_E_Park) February 26, 2024
On 28 February, eHCPs shared the announcement of a collaboration between AstraZeneca and oncology research organisation ‘Sarah Cannon Research Institute’ (SCRI). eHCPs particularly celebrated the shared goal of developing a model that widens patient access and improves delivery times for clinical trials. Oncologist Ishwaria Subbiah shared a news article detailing this collaboration, which was shared by a further 2 eHCPs.
An exciting day to announce our @SarahCannonDocs – @AstraZeneca partnership to drive #innovation in #clinicaltrials — this is how you broaden #clinicaltrial #access, advance new #cancer treatments, and advance #ClinicianWellbeing!
💡Streamlining #cancerresearch implementation is… https://t.co/t0P1Lomeuk— Ishwaria Subbiah, MD MS (@IshwariaMD) February 28, 2024
The top shared links by eHCPs when mentioning a Top 50 pharma company discussed:
- A YouTube video to the Pfizer Super Bowl advert.
- An article of the long term safety data of the Novavax COVID-19 vaccine.
- A Wikipedia article discussing the COVID-19 pandemic.
CREATION.co continues to analyse online eHCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.
To stay up to date, you can sign up to CREATION.co’s monthly eJournal.
Methodology notes:
-
- In February 2024, CREATION Pinpoint® identified 8,333 healthcare professional authored posts on X (Twitter) from 3,306 individual eHCPs mentioning a Top 50 Pharmaceutical company (according to revenue).
- Data for this research was analysed from the online X conversations of eHCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 – 29 February 2024.
- Unless otherwise specified, mentions of a company are not limited to its X account(s).
- In some cases, an X post may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
- Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Johnson & Johnson Innovative Medicine (previously Janssen). In February 2024, 41 of these posts mentioned Johnson & Johnson Innovative Medicine or Janssen.
